Navigation Links
Internet Entrepreneur Jason Hope Pledges Half a Million Dollars to SENS Foundation
Date:12/9/2010

MOUNTAIN VIEW, Calif., Dec. 9, 2010 /PRNewswire/ -- The global scientific community is increasingly recognizing the role of rejuvenation biotechnologies in addressing age-related disease. This week, Arizona-based businessman Jason Hope announced a $500,000 donation to SENS Foundation, a California-based non-profit organization that works to develop, promote and ensure widespread access to rejuvenation biotechnologies which comprehensively address age-related disease.  

"I have had great interest in the SENS Foundation and Dr. Aubrey de Grey's work for some time now.  I believe their work is essential to the advancement of human medicine and their approach to the overall problem of human aging and its associated diseases (Alzheimer's, Atherosclerosis, Diabetes, etc.) is the only way to go.  Their work and the work of others that they support will drive the complete redefinition and reshaping of the healthcare, pharmaceutical, and biotech industries as we know them today.  The advancement of rejuvenation biotechnologies is not only extremely important, but it is the future. I am honored to support the SENS Foundation in its efforts, and hope my support helps drive faster results for all of humanity," said Jason Hope.

The donation was announced by SENS Foundation CEO, Mike Kope, at Tuesday's 'Breakthrough Philanthropy' event hosted by the Thiel Foundation, in the Palace of Fine Arts in San Francisco.

"We need to create an entirely new biotech industry. That's why we created SENS Foundation: to be a credible catalyst for change; to be a public research and outreach organization devoted to the creation of a new field- rejuvenation biotechnology.  To that end, we are proud that our projects are capturing the imaginations of top tier collaborators in biotech and regenerative medicine.  Jason Hope's donation is a major contribution, enabling us to build on our existing collaborations in 2011, and accelerating our progress in the fight against age-related disease," said Mike Kope

"I enjoyed hearing a lot of great presentations at the Breakthrough Philanthropy event," said Thiel Foundation chairman Peter Thiel. "But for me, the highlight of the whole evening was hearing about Jason's bold commitment to defeating aging."

SENS Foundation CSO, Aubrey de Grey, described the use to which Hope's donation will be put:

"Arteriosclerosis - hardening of the arteries - is the main cause of increased blood pressure (hypertension) in the elderly, which in turn exacerbates major aspects of aging such as diabetes. It is caused largely by the unwanted accumulation of molecular bonds between the proteins that hold the cells of the artery in place - the extracellular matrix. The same process causes long-sightedness (presbyopia) and contributes to skin aging. I am delighted that Jason's donation will fund our work on the pharmacological breaking of these unwanted molecular bonds, and the restoration of elasticity to the body's extracellular matrix."

To view Mike Kope's announcement of Jason Hope's donation at Tuesday's 'Breakthrough Philanthropy' event and to learn more about SENS Foundation visit: http://sens.org/node/1858

About Jason Hope

Jason Hope is an entrepreneur, based in Scottsdale, AZ, with a passion for philanthropy focusing on education, disease cure, scientific research and biotechnology.  An Arizona native, Hope is a strong supporter of local educational programs that encourage learning inside and out of the classroom as well as those organizations that have a significant impact on disease prevention, control and cures.  Hope has worked with the Boys & Girls Club of Metropolitan Phoenix, the Leukemia & Lymphoma Society's Desert Mountain States Chapter, The Tony Hawk Foundation, The Andre Agassi Foundation, True Colors Fund, The Mark Wahlberg Youth Foundation, Family Health International, Worldwide Orphans Foundation, T Gen Foundation, Teach for America Phoenix, International Foundation for Education and Self Help and the Arizona Science Center, where he is a member of the Director's Circle.

About SENS Foundation : www.sens.org

SENS Foundation is a non-profit organization founded in 2009 to develop, promote and ensure widespread access to rejuvenation biotechnologies which comprehensively address age-related disease.  Our focus is SENS, a framework for repairing the damage which builds up in the body as a result of normal metabolism, before that damage leads to the development of deadly pathologies.


'/>"/>
SOURCE SENS Foundation
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Universal Bioenergy, Inc. Expressly Disclaims Any Responsibility for the Content, Accuracy of Information, and Quality of Information Regarding Universal Published by Any Third-Party and Being Disseminated on the Internet
2. New organic material may speed Internet access
3. Internet can warn of ecological changes
4. IGEN Networks signs Exclusive Agreement with Machlink, for wireless technology with high-speed Internet, phone and data applications
5. A Fresh Approach to Marketing: Dr. Fresh™, Inc. Goes Guerilla With Internet-Based Campaigns
6. KGI Entrepreneur Program Hosts Angel Investing Educational Meeting
7. General Patent Corporation Calls New Patent Reform Bill Harmful to Inventors and Entrepreneurs
8. Moleac Named Singapore Entrepreneurial Company of the Year at the Frost & Sullivan Excellence in Healthcare Awards
9. Xconomy Launches XSITE 2009; First Annual Xconomy Summit on Innovation, Technology, and Entrepreneurship at Boston University
10. Dendreon Corporation CEO Mitchell H. Gold, M.D. Named Ernst & Young Entrepreneur of the Year(R) 2009 Award Finalist in the Pacific Northwest
11. Knighted Adds Industry Pioneer and Entrepreneur to Senior Management Team
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... , June 23, 2016   Boston Biomedical ... novel compounds designed to target cancer stemness pathways, ... been granted Orphan Drug Designation from the U.S. ... of gastric cancer, including gastroesophageal junction (GEJ) cancer. ... designed to inhibit cancer stemness pathways by targeting ...
(Date:6/23/2016)... , June 23, 2016  The Prostate Cancer Foundation (PCF) is ... treatments and faster cures for prostate cancer. Members of the Class of 2016 ... countries. Read More About the Class of 2016 PCF ... ... ...
(Date:6/23/2016)... ... 2016 , ... In a new case report published today in STEM CELLS ... developed lymphedema after being treated for breast cancer benefitted from an injection of stem ... with this debilitating, frequent side effect of cancer treatment. , Lymphedema refers ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... at the Pennsylvania Convention Center and will showcase its product’s latest features from ... also be presenting a scientific poster on Disrupting Clinical Trials in The Cloud ...
Breaking Biology Technology:
(Date:4/28/2016)... First quarter 2016:   , Revenues amounted ... quarter of 2015 The gross margin was 49% (27) ... the operating margin was 40% (-13) Earnings per share ... operations was SEK 249.9 M (21.2) , Outlook   ... M. The operating margin for 2016 is estimated to ...
(Date:4/15/2016)... -- Research and Markets has announced the ...  report to their offering.  ,      ... gait biometrics market is expected to grow at ... Gait analysis generates multiple variables such ... compute factors that are not or cannot be ...
(Date:3/29/2016)... RATON, Florida , March 29, 2016 ... or the "Company") LegacyXChange "LEGX" and SelectaDNA/CSI Protect are ... DNA in ink used in a variety of writing ... theft. Buyers of originally created collectibles from athletes on ... through forensic analysis of the DNA. ...
Breaking Biology News(10 mins):